APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plasma Derived Medicine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Plasma Derived Medicine Industry Growth and Trends Forecast to 2032

31 December 2025114 pages

Choose your research edition.

Industry ResearchPlasma Derived Medicine Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasma Derived Medicine Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Plasma Derived Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasma Derived Medicine Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasma Derived Medicine Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

According to APO Research, the global Plasma Derived Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Plasma Derived Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Plasma Derived Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plasma Derived Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Plasma Derived Medicine market include Yuanda Shuyang, Takeda, Weiguang Bio, Tiantan Bio, CBPO, Shuanglin Bio, RAAS, Nanyue Bio and Hualan Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Plasma Derived Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Plasma Derived Medicine market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Plasma Derived Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Plasma Derived Medicine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Plasma Derived Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Plasma Derived Medicine Market by Company

Yuanda Shuyang

Takeda

Weiguang Bio

Tiantan Bio

CBPO

Shuanglin Bio

RAAS

Nanyue Bio

Hualan Bio

Boya Bio

Octapharma

LFB Group

KM Biologics

Kedrion

Grifols

CSL

BPL

Biotest

Plasma Derived Medicine Segment by Type

Albumin

Immune Globulin

Coagulation Factor

Others

Plasma Derived Medicine Segment by Application

Hospital

Retail Pharmacy

Other

Plasma Derived Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Derived Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma Derived Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Derived Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Plasma Derived Medicine companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Plasma Derived Medicine Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Plasma Derived Medicine Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Plasma Derived Medicine Market Share by Region (2021-2026) Table 4. Global Plasma Derived Medicine Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Plasma Derived Medicine Market Share by Region (2027-2032) Table 6. Global Plasma Derived Medicine Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Plasma Derived Medicine Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Plasma Derived Medicine Market Size Share by Type (2021-2026) Table 9. Global Plasma Derived Medicine Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Plasma Derived Medicine Market Size Share Forecasted by Type (2027-2032) Table 11. North America Plasma Derived Medicine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Plasma Derived Medicine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Plasma Derived Medicine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Plasma Derived Medicine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Plasma Derived Medicine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Plasma Derived Medicine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Plasma Derived Medicine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Plasma Derived Medicine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Plasma Derived Medicine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Plasma Derived Medicine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Plasma Derived Medicine Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Plasma Derived Medicine Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Plasma Derived Medicine Market Size Share by Application (2021-2026) Table 24. Global Plasma Derived Medicine Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Plasma Derived Medicine Market Size Share Forecasted by Application (2027-2032) Table 26. North America Plasma Derived Medicine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Plasma Derived Medicine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Plasma Derived Medicine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Plasma Derived Medicine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Plasma Derived Medicine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Plasma Derived Medicine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Plasma Derived Medicine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Plasma Derived Medicine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Plasma Derived Medicine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Plasma Derived Medicine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Plasma Derived Medicine Industry Trends Table 37. Plasma Derived Medicine Industry Drivers Table 38. Plasma Derived Medicine Industry Opportunities and Challenges Table 39. Plasma Derived Medicine Industry Restraints Table 40. Global Plasma Derived Medicine Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Plasma Derived Medicine Revenue Market Share by Company (2021-2026) Table 42. Global Plasma Derived Medicine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Plasma Derived Medicine Key Company Headquarters & Area Served Table 44. Global Plasma Derived Medicine Company, Product Type & Application Table 45. Global Plasma Derived Medicine Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Plasma Derived Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Yuanda Shuyang Company Information Table 49. Yuanda Shuyang Business Overview Table 50. Yuanda Shuyang Plasma Derived Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Yuanda Shuyang Plasma Derived Medicine Product Portfolio Table 52. Yuanda Shuyang Recent Development Table 53. Takeda Company Information Table 54. Takeda Business Overview Table 55. Takeda Plasma Derived Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Takeda Plasma Derived Medicine Product Portfolio Table 57. Takeda Recent Development Table 58. Weiguang Bio Company Information Table 59. Weiguang Bio Business Overview Table 60. Weiguang Bio Plasma Derived Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Weiguang Bio Plasma Derived Medicine Product Portfolio Table 62. Weiguang Bio Recent Development Table 63. Tiantan Bio Company Information Table 64. Tiantan Bio Business Overview Table 65. Tiantan Bio Plasma Derived Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Tiantan Bio Plasma Derived Medicine Product Portfolio Table 67. Tiantan Bio Recent Development Table 68. CBPO Company Information Table 69. CBPO Business Overview Table 70. CBPO Plasma Derived Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. CBPO Plasma Derived Medicine Product Portfolio Table 72. CBPO Recent Development Table 73. Shuanglin Bio Company Information Table 74. Shuanglin Bio Business Overview Table 75. Shuanglin Bio Plasma Derived Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Shuanglin Bio Plasma Derived Medicine Product Portfolio Table 77. Shuanglin Bio Recent Development Table 78. RAAS Company Information Table 79. RAAS Business Overview Table 80. RAAS Plasma Derived Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. RAAS Plasma Derived Medicine Product Portfolio Table 82. RAAS Recent Development Table 83. Nanyue Bio Company Information Table 84. Nanyue Bio Business Overview Table 85. Nanyue Bio Plasma Derived Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Nanyue Bio Plasma Derived Medicine Product Portfolio Table 87. Nanyue Bio Recent Development Table 88. Hualan Bio Company Information Table 89. Hualan Bio Business Overview Table 90. Hualan Bio Plasma Derived Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Hualan Bio Plasma Derived Medicine Product Portfolio Table 92. Hualan Bio Recent Development Table 93. Boya Bio Company Information Table 94. Boya Bio Business Overview Table 95. Boya Bio Plasma Derived Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Boya Bio Plasma Derived Medicine Product Portfolio Table 97. Boya Bio Recent Development Table 98. Octapharma Company Information Table 99. Octapharma Business Overview Table 100. Octapharma Plasma Derived Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Octapharma Plasma Derived Medicine Product Portfolio Table 102. Octapharma Recent Development Table 103. LFB Group Company Information Table 104. LFB Group Business Overview Table 105. LFB Group Plasma Derived Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. LFB Group Plasma Derived Medicine Product Portfolio Table 107. LFB Group Recent Development Table 108. KM Biologics Company Information Table 109. KM Biologics Business Overview Table 110. KM Biologics Plasma Derived Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. KM Biologics Plasma Derived Medicine Product Portfolio Table 112. KM Biologics Recent Development Table 113. Kedrion Company Information Table 114. Kedrion Business Overview Table 115. Kedrion Plasma Derived Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Kedrion Plasma Derived Medicine Product Portfolio Table 117. Kedrion Recent Development Table 118. Grifols Company Information Table 119. Grifols Business Overview Table 120. Grifols Plasma Derived Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Grifols Plasma Derived Medicine Product Portfolio Table 122. Grifols Recent Development Table 123. CSL Company Information Table 124. CSL Business Overview Table 125. CSL Plasma Derived Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. CSL Plasma Derived Medicine Product Portfolio Table 127. CSL Recent Development Table 128. BPL Company Information Table 129. BPL Business Overview Table 130. BPL Plasma Derived Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. BPL Plasma Derived Medicine Product Portfolio Table 132. BPL Recent Development Table 133. Biotest Company Information Table 134. Biotest Business Overview Table 135. Biotest Plasma Derived Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Biotest Plasma Derived Medicine Product Portfolio Table 137. Biotest Recent Development Table 138. North America Plasma Derived Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Plasma Derived Medicine Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Plasma Derived Medicine Market Share by Country (2021-2026) Table 141. North America Plasma Derived Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Plasma Derived Medicine Market Share Forecast by Country (2027-2032) Table 143. Europe Plasma Derived Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Plasma Derived Medicine Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Plasma Derived Medicine Market Share by Country (2021-2026) Table 146. Europe Plasma Derived Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Plasma Derived Medicine Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Plasma Derived Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Plasma Derived Medicine Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Plasma Derived Medicine Market Share by Country (2021-2026) Table 151. Asia-Pacific Plasma Derived Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Plasma Derived Medicine Market Share Forecast by Country (2027-2032) Table 153. Latin America Plasma Derived Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Plasma Derived Medicine Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Plasma Derived Medicine Market Share by Country (2021-2026) Table 156. Latin America Plasma Derived Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Plasma Derived Medicine Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Plasma Derived Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Plasma Derived Medicine Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Plasma Derived Medicine Market Share by Country (2021-2026) Table 161. Middle East & Africa Plasma Derived Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Plasma Derived Medicine Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Plasma Derived Medicine Product Image Figure 3. Global Plasma Derived Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Plasma Derived Medicine Market Size (2021-2032) & (US$ Million) Figure 5. Global Plasma Derived Medicine Market Share by Region: 2025 VS 2032 Figure 6. Global Plasma Derived Medicine Market Share by Region (2021-2032) Figure 7. North America Plasma Derived Medicine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Plasma Derived Medicine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Plasma Derived Medicine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Plasma Derived Medicine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Plasma Derived Medicine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Albumin Image Figure 13. Global Albumin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Immune Globulin Image Figure 15. Global Immune Globulin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Coagulation Factor Image Figure 17. Global Coagulation Factor Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Plasma Derived Medicine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Plasma Derived Medicine Market Share by Type 2025 VS 2032 Figure 22. North America Plasma Derived Medicine Market Size Share by Type (2021-2032) Figure 23. Europe Plasma Derived Medicine Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Plasma Derived Medicine Market Size Share by Type (2021-2032) Figure 25. Latin America Plasma Derived Medicine Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Plasma Derived Medicine Market Size Share by Type (2021-2032) Figure 27. Hospital Image Figure 28. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Retail Pharmacy Image Figure 30. Global Retail Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Other Image Figure 32. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Plasma Derived Medicine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Plasma Derived Medicine Market Share by Application 2025 VS 2032 Figure 35. North America Plasma Derived Medicine Market Size Share by Application (2021-2032) Figure 36. Europe Plasma Derived Medicine Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Plasma Derived Medicine Market Size Share by Application (2021-2032) Figure 38. Latin America Plasma Derived Medicine Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Plasma Derived Medicine Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Plasma Derived Medicine Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Plasma Derived Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Plasma Derived Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Plasma Derived Medicine Market Share by Country (2021-2032) Figure 45. Europe Plasma Derived Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Plasma Derived Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Plasma Derived Medicine Market Share by Country (2021-2032) Figure 48. Asia-Pacific Plasma Derived Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Plasma Derived Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Plasma Derived Medicine Market Share by Country (2021-2032) Figure 51. Latin America Plasma Derived Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Plasma Derived Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Plasma Derived Medicine Market Share by Country (2021-2032) Figure 54. Middle East & Africa Plasma Derived Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Plasma Derived Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Plasma Derived Medicine Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Albumin
  • Immune Globulin
  • Coagulation Factor
  • Others
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Yuanda Shuyang
  • Takeda
  • Weiguang Bio
  • Tiantan Bio
  • CBPO
  • Shuanglin Bio
  • RAAS
  • Nanyue Bio
  • Hualan Bio
  • Boya Bio
  • Octapharma
  • LFB Group
  • KM Biologics
  • Kedrion
  • Grifols
  • CSL
  • BPL
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Plasma Derived Medicine Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Plasma Derived Medicine Market Size by Region (2021-2032)
  5. 1.4.1 Global Plasma Derived Medicine Market Size by Region (2021-2026)
  6. 1.4.2 Global Plasma Derived Medicine Market Size by Region (2027-2032)
  7. 1.5 Key Regions Plasma Derived Medicine Market Size (2021-2032)
  8. 1.5.1 North America Plasma Derived Medicine Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Plasma Derived Medicine Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Plasma Derived Medicine Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Plasma Derived Medicine Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Plasma Derived Medicine Market Size Growth Rate (2021-2032)
2 Plasma Derived Medicine Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Albumin
  3. 2.1.2 Immune Globulin
  4. 2.1.3 Coagulation Factor
  5. 2.1.4 Others
  6. 2.2 Global Plasma Derived Medicine Market Size by Type
  7. 2.2.1 Global Plasma Derived Medicine Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Plasma Derived Medicine Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Plasma Derived Medicine Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Plasma Derived Medicine Market Size by Regions
  11. 2.3.1 North America Plasma Derived Medicine Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Plasma Derived Medicine Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Plasma Derived Medicine Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Plasma Derived Medicine Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Plasma Derived Medicine Market Size Breakdown by Type (2021-2026)
3 Plasma Derived Medicine Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Retail Pharmacy
  4. 3.1.3 Other
  5. 3.2 Global Plasma Derived Medicine Market Size by Application
  6. 3.2.1 Global Plasma Derived Medicine Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Plasma Derived Medicine Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Plasma Derived Medicine Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Plasma Derived Medicine Market Size by Regions
  10. 3.3.1 North America Plasma Derived Medicine Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Plasma Derived Medicine Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Plasma Derived Medicine Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Plasma Derived Medicine Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Plasma Derived Medicine Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Plasma Derived Medicine Industry Trends
  2. 4.2 Plasma Derived Medicine Industry Drivers
  3. 4.3 Plasma Derived Medicine Industry Opportunities and Challenges
  4. 4.4 Plasma Derived Medicine Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Plasma Derived Medicine Revenue (2021-2026)
  2. 5.2 Global Plasma Derived Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Plasma Derived Medicine Key Company Headquarters & Area Served
  4. 5.4 Global Plasma Derived Medicine Company, Product Type & Application
  5. 5.5 Global Plasma Derived Medicine Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Plasma Derived Medicine Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Plasma Derived Medicine Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Plasma Derived Medicine Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Yuanda Shuyang
  2. 6.1.1 Yuanda Shuyang Company Information
  3. 6.1.2 Yuanda Shuyang Business Overview
  4. 6.1.3 Yuanda Shuyang Plasma Derived Medicine Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Yuanda Shuyang Plasma Derived Medicine Product Portfolio
  6. 6.1.5 Yuanda Shuyang Recent Developments
  7. 6.2 Takeda
  8. 6.2.1 Takeda Company Information
  9. 6.2.2 Takeda Business Overview
  10. 6.2.3 Takeda Plasma Derived Medicine Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Takeda Plasma Derived Medicine Product Portfolio
  12. 6.2.5 Takeda Recent Developments
  13. 6.3 Weiguang Bio
  14. 6.3.1 Weiguang Bio Company Information
  15. 6.3.2 Weiguang Bio Business Overview
  16. 6.3.3 Weiguang Bio Plasma Derived Medicine Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Weiguang Bio Plasma Derived Medicine Product Portfolio
  18. 6.3.5 Weiguang Bio Recent Developments
  19. 6.4 Tiantan Bio
  20. 6.4.1 Tiantan Bio Company Information
  21. 6.4.2 Tiantan Bio Business Overview
  22. 6.4.3 Tiantan Bio Plasma Derived Medicine Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Tiantan Bio Plasma Derived Medicine Product Portfolio
  24. 6.4.5 Tiantan Bio Recent Developments
  25. 6.5 CBPO
  26. 6.5.1 CBPO Company Information
  27. 6.5.2 CBPO Business Overview
  28. 6.5.3 CBPO Plasma Derived Medicine Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 CBPO Plasma Derived Medicine Product Portfolio
  30. 6.5.5 CBPO Recent Developments
  31. 6.6 Shuanglin Bio
  32. 6.6.1 Shuanglin Bio Company Information
  33. 6.6.2 Shuanglin Bio Business Overview
  34. 6.6.3 Shuanglin Bio Plasma Derived Medicine Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Shuanglin Bio Plasma Derived Medicine Product Portfolio
  36. 6.6.5 Shuanglin Bio Recent Developments
  37. 6.7 RAAS
  38. 6.7.1 RAAS Company Information
  39. 6.7.2 RAAS Business Overview
  40. 6.7.3 RAAS Plasma Derived Medicine Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 RAAS Plasma Derived Medicine Product Portfolio
  42. 6.7.5 RAAS Recent Developments
  43. 6.8 Nanyue Bio
  44. 6.8.1 Nanyue Bio Company Information
  45. 6.8.2 Nanyue Bio Business Overview
  46. 6.8.3 Nanyue Bio Plasma Derived Medicine Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Nanyue Bio Plasma Derived Medicine Product Portfolio
  48. 6.8.5 Nanyue Bio Recent Developments
  49. 6.9 Hualan Bio
  50. 6.9.1 Hualan Bio Company Information
  51. 6.9.2 Hualan Bio Business Overview
  52. 6.9.3 Hualan Bio Plasma Derived Medicine Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Hualan Bio Plasma Derived Medicine Product Portfolio
  54. 6.9.5 Hualan Bio Recent Developments
  55. 6.10 Boya Bio
  56. 6.10.1 Boya Bio Company Information
  57. 6.10.2 Boya Bio Business Overview
  58. 6.10.3 Boya Bio Plasma Derived Medicine Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Boya Bio Plasma Derived Medicine Product Portfolio
  60. 6.10.5 Boya Bio Recent Developments
  61. 6.11 Octapharma
  62. 6.11.1 Octapharma Company Information
  63. 6.11.2 Octapharma Business Overview
  64. 6.11.3 Octapharma Plasma Derived Medicine Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Octapharma Plasma Derived Medicine Product Portfolio
  66. 6.11.5 Octapharma Recent Developments
  67. 6.12 LFB Group
  68. 6.12.1 LFB Group Company Information
  69. 6.12.2 LFB Group Business Overview
  70. 6.12.3 LFB Group Plasma Derived Medicine Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 LFB Group Plasma Derived Medicine Product Portfolio
  72. 6.12.5 LFB Group Recent Developments
  73. 6.13 KM Biologics
  74. 6.13.1 KM Biologics Company Information
  75. 6.13.2 KM Biologics Business Overview
  76. 6.13.3 KM Biologics Plasma Derived Medicine Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 KM Biologics Plasma Derived Medicine Product Portfolio
  78. 6.13.5 KM Biologics Recent Developments
  79. 6.14 Kedrion
  80. 6.14.1 Kedrion Company Information
  81. 6.14.2 Kedrion Business Overview
  82. 6.14.3 Kedrion Plasma Derived Medicine Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Kedrion Plasma Derived Medicine Product Portfolio
  84. 6.14.5 Kedrion Recent Developments
  85. 6.15 Grifols
  86. 6.15.1 Grifols Company Information
  87. 6.15.2 Grifols Business Overview
  88. 6.15.3 Grifols Plasma Derived Medicine Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Grifols Plasma Derived Medicine Product Portfolio
  90. 6.15.5 Grifols Recent Developments
  91. 6.16 CSL
  92. 6.16.1 CSL Company Information
  93. 6.16.2 CSL Business Overview
  94. 6.16.3 CSL Plasma Derived Medicine Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 CSL Plasma Derived Medicine Product Portfolio
  96. 6.16.5 CSL Recent Developments
  97. 6.17 BPL
  98. 6.17.1 BPL Company Information
  99. 6.17.2 BPL Business Overview
  100. 6.17.3 BPL Plasma Derived Medicine Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 BPL Plasma Derived Medicine Product Portfolio
  102. 6.17.5 BPL Recent Developments
  103. 6.18 Biotest
  104. 6.18.1 Biotest Company Information
  105. 6.18.2 Biotest Business Overview
  106. 6.18.3 Biotest Plasma Derived Medicine Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Biotest Plasma Derived Medicine Product Portfolio
  108. 6.18.5 Biotest Recent Developments
7 North America
  1. 7.1 North America Plasma Derived Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Plasma Derived Medicine Market Size by Country (2021-2026)
  3. 7.3 North America Plasma Derived Medicine Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Plasma Derived Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Plasma Derived Medicine Market Size by Country (2021-2026)
  3. 8.3 Europe Plasma Derived Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Plasma Derived Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Plasma Derived Medicine Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Plasma Derived Medicine Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Plasma Derived Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Plasma Derived Medicine Market Size by Country (2021-2026)
  3. 10.3 South America Plasma Derived Medicine Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Plasma Derived Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Plasma Derived Medicine Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Plasma Derived Medicine Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst